GAFFX
Price
$82.92
Change
+$0.81 (+0.99%)
Updated
Jul 3 closing price
Net Assets
322.86B
PJFZX
Price
$75.24
Change
+$0.96 (+1.29%)
Updated
Jul 3 closing price
Net Assets
8.79B
Interact to see
Advertisement

GAFFX vs PJFZX

Header iconGAFFX vs PJFZX Comparison
Open Charts GAFFX vs PJFZXBanner chart's image
American Funds Growth Fund of Amer F3
Price$82.92
Change+$0.81 (+0.99%)
VolumeN/A
Net Assets322.86B
PGIM Jennison Growth Z
Price$75.24
Change+$0.96 (+1.29%)
VolumeN/A
Net Assets8.79B
GAFFX vs PJFZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GAFFX vs. PJFZX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and PJFZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 323B vs. PJFZX (8.79B). GAFFX pays higher dividends than PJFZX: GAFFX (0.61) vs PJFZX (0.00). GAFFX was incepted earlier than PJFZX: GAFFX (8 years) vs PJFZX (29 years). PJFZX (0.69) is less costly to investors than GAFFX (0.30). PJFZX is a more actively managed with annual turnover of: 37.00 vs. GAFFX (25.00). PJFZX has a lower initial minimum investment than GAFFX: PJFZX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 11.26 vs. PJFZX (3.88). GAFFX return over 5 years is better than : 51.33 vs. PJFZX (35.54).
GAFFXPJFZXGAFFX / PJFZX
Total Expense Ratio0.300.6943%
Annual Report Gross Expense Ratio0.300.6943%
Fund Existence8 years29 years-
Gain YTD11.3478.368136%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets323B8.79B3,674%
Annual Yield % from dividends0.610.00-
Returns for 1 year11.263.88290%
Returns for 3 years60.9373.2483%
Returns for 5 years51.3335.54144%
Returns for 10 yearsN/A128.59-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEUP7.130.11
+1.57%
Neuphoria Therapeutics Inc
NTAP107.260.17
+0.16%
NetApp
SAMG16.52-0.03
-0.18%
Silvercrest Asset Management Group
PHAR10.58-0.07
-0.66%
Pharming Group NV
UAA7.11-0.11
-1.52%
Under Armour